Molecular Breast Imaging (MBI) in Patients With Atypical Ductal Hyperplasia (ADH), Atypical Lobular Hyperplasia (ALH), or Lobular Carcinoma In Situ (LCIS)
| Status: | Archived |
|---|---|
| Conditions: | Breast Cancer, Cancer, Hematology |
| Therapuetic Areas: | Hematology, Oncology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | October 2003 |
| End Date: | February 2015 |
Evaluation of a Small Field of View Gamma Camera for Scintimammography in Patients With Atypical Ductal Hyperplasia, Atypical Lobular Hyperplasia, and Lobular Carcinoma In Situ
This study is being done to test the ability of an investigational breast imaging camera to
distinguish between cancerous tumors in the breast and tumors in the breast which are benign
(not cancerous) but increase the risk of developing breast cancer. A preliminary study with
this camera suggests that it is at least as accurate as a standard mammogram in the
detection of small breast cancers.
The purpose behind this observational study is that a small, specialized gamma camera system
optimized for scintimammography can identify malignant breast lesions that may be
mammographically occult in women with core biopsy-proven atypical ductal hyperplasia,
atypical lobular hyperplasia, and lobular carcinoma in situ. In addition, we aim to study
this gamma camera system as an imaging surveillance tool in these women at increased risk
for developing invasive breast carcinoma.
We found this trial at
1
site
Mayo Clinic Rochester Mayo Clinic is a nonprofit worldwide leader in medical care, research and...
Click here to add this to my saved trials
